Evidence map›Paper›PMID 25627033›Full record

ArticleMalaria journal2015

Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies.

Susanne H Hodgson, Alexander D Douglas, Nick J Edwards, Domtila Kimani, Sean C Elias, Ming Chang, Glenda Daza, Annette M Seilie, Charles Magiri, Alfred Muia and 12 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Open forum infectious diseases · 2023
    Article
  6. Molecular therapy. Methods & clinical development · 2022
    Article
  7. AiScience · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Beyond Blood Smears: Qualification ofThe American journal of tropical medicine and hygiene · 2019
    Article
  14. Simultaneous Quantification ofJournal of clinical microbiology · 2019
    Article
  15. Article
  16. Article
  17. Performance of a High-Sensitivity Rapid Diagnostic Test forThe American journal of tropical medicine and hygiene · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 3 countries.

Susanne H HodgsonThe Jenner Institute, University of Oxford, Oxford, UK. susanne.hodgson@ndm.ox.ac.uk.
Alexander D DouglasThe Jenner Institute, University of Oxford, Oxford, UK. sandy.douglas@ndm.ox.ac.uk.
Nick J EdwardsThe Jenner Institute, University of Oxford, Oxford, UK. nick.edwards@ndm.ox.ac.uk.
Domtila KimaniKenya Medical Research Institute - Wellcome Trust, Centre for Geographical Medical Research (Coast), Kilifi, Kenya. dkimani@kilifi.kemri-wellcome.org.
Sean C EliasThe Jenner Institute, University of Oxford, Oxford, UK. sean.elias@ndm.ox.ac.uk.
Ming ChangDepartment of Laboratory Medicine and Center for Emerging and Re-Emerging Infectious Diseases, University of Washington (UW), 750 Republican St., E633, Seattle, WA, 98109, USA. minchang@u.washington.edu.
Glenda DazaDepartment of Laboratory Medicine and Center for Emerging and Re-Emerging Infectious Diseases, University of Washington (UW), 750 Republican St., E633, Seattle, WA, 98109, USA. gdaza@uw.edu.
Annette M SeilieDepartment of Laboratory Medicine and Center for Emerging and Re-Emerging Infectious Diseases, University of Washington (UW), 750 Republican St., E633, Seattle, WA, 98109, USA. amseilie@uw.edu.
Charles MagiriCentre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya. charles.magiri@usamru-k.org.
Alfred MuiaCentre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya. dealfremmdoh@yahoo.com.
Elizabeth A JumaCentre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya. jumaelizabeth@yahoo.com.
Andrew O ColeCentre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya. omandi.cole@gmail.com.
Thomas W RamplingThe Jenner Institute, University of Oxford, Oxford, UK. thomas.rampling@ndm.ox.ac.uk.
Nicholas A AnagnostouThe Jenner Institute, University of Oxford, Oxford, UK. Nickanag@gmail.com.
Sarah C GilbertThe Jenner Institute, University of Oxford, Oxford, UK. sarah.gilbert@ndm.ox.ac.uk.
Stephen L HoffmanSanaria, Inc, Rockville, MD, USA. slhoffman@sanaria.com.
Simon J DraperThe Jenner Institute, University of Oxford, Oxford, UK. simon.draper@merton.ox.ac.uk.
Philip BejonKenya Medical Research Institute - Wellcome Trust, Centre for Geographical Medical Research (Coast), Kilifi, Kenya. pbejon@well.ox.ac.uk.
Bernhards OgutuCentre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya. bernhards.ogutu@indepth-network.org.
Kevin MarshKenya Medical Research Institute - Wellcome Trust, Centre for Geographical Medical Research (Coast), Kilifi, Kenya. kevin.marsh@ndm.ox.ac.uk.
Adrian V S HillThe Jenner Institute, University of Oxford, Oxford, UK. adrian.hill@ndm.ox.ac.uk.
Sean C MurphyDepartment of Laboratory Medicine and Center for Emerging and Re-Emerging Infectious Diseases, University of Washington (UW), 750 Republican St., E633, Seattle, WA, 98109, USA. murphysc@uw.edu.
Jenner Institute · GBKenya Medical Research Institute · KEUniversity of Washington · USUniversity of Oxford · GBSanaria · USStrathmore University · KE

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Universal Attenuated Sporozoite Vaccine and Challenge SystemR44AI058375 · NIAID · SANARIA, INC. · PI HOFFMAN, STEPHEN LEV · 2006 to 2018
$9.9M
Identification of responding CD8+ T cells and novel protective epitopes followingK08AI097238 · NIAID · UNIVERSITY OF WASHINGTON · PI MURPHY, SEAN C · 2011 to 2015
$633k
Medical Research Council G1000527Medical Research Council G1002624NIAID NIH HHS K08 AI097238NIAID NIH HHS K08AI097238NIAID NIH HHS P30 AI027757NIAID NIH HHS R44 AI058375NIAID NIH HHS R44AI058375Wellcome Trust 092654Wellcome Trust 097940/Z/11/ZWellcome Trust 45488/Z/05
6 · The paper itself

Abstract

backgroundControlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood of infected participants. The lower limits of detection and quantification vary amongst the assays used throughout the world, which may affect the ability of mathematical models to accurately estimate the liver-to-blood inoculum (LBI) values that are used to judge the efficacy of pre-erythrocytic vaccine and drug candidates.

methodsSamples were collected around the time of onset of pre-patent parasitaemia from subjects who enrolled in two different CHMI clinical trials. Blood samples were tested for Plasmodium falciparum 18S rRNA and/or rDNA targets by different NAT methods and results were compared. Methods included an ultrasensitive, large volume modification of an established quantitative reverse transcription PCR (qRT-PCR) assay that achieves detection of as little as one parasite/mL of whole blood.

resultsLarge volume qRT-PCR at the University of Washington was the most sensitive test and generated quantifiable data more often than any other NAT methodology. Standard quantitative PCR (qPCR) performed at the University of Oxford and standard volume qRT-PCR performed at the University of Washington were less sensitive than the large volume qRT-PCR, especially at 6.5 days after CHMI. In these trials, the proportion of participants for whom LBI could be accurately quantified using parasite density value greater than or equal to the lower limit of quantification was increased. A greater improvement would be expected in trials in which numerous subjects receive a lower LBI or low dose challenge.

conclusionsStandard qPCR and qRT-PCR methods with analytical sensitivities of ~20 parasites/mL probably suffice for most CHMI purposes, but the newly developed large volume qRT-PCR may be able to answer specific questions when more analytical sensitivity is required.

Indexed as

AdultDNA, ProtozoanFemaleHumansLimit of DetectionMalariaMaleMiddle AgedMolecular Diagnostic TechniquesParasitemiaPolymerase Chain ReactionRNA, Ribosomal, 18SYoung AdultDNA, ProtozoanRNA, Ribosomal, 18S

Identifiers

PMID25627033
PMCPMC4318195
OpenAlexW2133266690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.